Cipargamin

N/A

Report date: 2026/03/14 20:00:17
NME

Base Information

Drug NameCipargamin
Drug Alias Name西帕加明CipargaminaCipargaminumCipargamineNITD-609 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionP-type ATPase4 inhibitors
TargetsP-type ATPase4
Therapy Area/IndicationsMalaria, FalciparumMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumVietnamUganda +[13] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma Ag
Inactive CompaniesN/A
Active IndicationsMalaria, FalciparumMalaria
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipedia